Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cAMP binding	PDE2A HCN4 HCN3	2.02e-04	25	92	3	GO:0030552
GeneOntologyMolecularFunction	neuroligin family protein binding	NRXN3 NRXN1	2.08e-04	5	92	2	GO:0097109
GeneOntologyMolecularFunction	fibroblast growth factor receptor binding	NRXN1 FRS3 FRS2	3.17e-04	29	92	3	GO:0005104
GeneOntologyMolecularFunction	intracellularly ligand-gated monoatomic ion channel activity	HCN4 HCN3 RYR2	4.67e-04	33	92	3	GO:0005217
GeneOntologyMolecularFunction	signal recognition particle binding	DERL3 DERL2	5.77e-04	8	92	2	GO:0005047
GeneOntologyMolecularFunction	protein tyrosine kinase binding	CSK PIK3R2 FRS3 FRS2 PCNA	6.31e-04	149	92	5	GO:1990782
GeneOntologyMolecularFunction	cyclic nucleotide binding	PDE2A HCN4 HCN3	7.67e-04	39	92	3	GO:0030551
GeneOntologyMolecularFunction	receptor tyrosine kinase binding	PIK3R2 FRS3 FRS2 PCNA	7.97e-04	90	92	4	GO:0030971
GeneOntologyMolecularFunction	intracellularly cAMP-activated cation channel activity	HCN4 HCN3	9.22e-04	10	92	2	GO:0005222
GeneOntologyMolecularFunction	phosphatidylinositol 3-kinase binding	MET PDGFRB PIK3R2	1.02e-03	43	92	3	GO:0043548
GeneOntologyMolecularFunction	semaphorin receptor activity	MET PLXNB1	1.34e-03	12	92	2	GO:0017154
GeneOntologyMolecularFunction	intracellularly cyclic nucleotide-activated monoatomic cation channel activity	HCN4 HCN3	1.58e-03	13	92	2	GO:0005221
GeneOntologyMolecularFunction	cyclic nucleotide-activated monoatomic ion channel activity	HCN4 HCN3	1.58e-03	13	92	2	GO:0043855
GeneOntologyBiologicalProcess	negative regulation of intracellular transport	PKIG RBM10 DERL3 DERL2 ARHGAP8	8.15e-06	61	93	5	GO:0032387
GeneOntologyBiologicalProcess	establishment or maintenance of polarity of embryonic epithelium	LLGL2 WNT7B	6.02e-05	3	93	2	GO:0016332
GeneOntologyBiologicalProcess	circulatory system development	MET PDE2A STAB2 LLGL2 NRXN3 NRXN1 HCN4 ADAMTS6 PDGFRB WNT2 PIK3R2 RBM10 WNT7B FRS2 IRX3 MMP9 RYR2 PCNA	6.78e-05	1442	93	18	GO:0072359
GeneOntologyBiologicalProcess	neural precursor cell proliferation	DAGLB WNT2 WNT7B FRS2 BBS1 NUMB NDUFS2	8.91e-05	233	93	7	GO:0061351
GeneOntologyBiologicalProcess	cellular response to cAMP	PDE2A HCN4 HCN3 CRHBP	9.58e-05	53	93	4	GO:0071320
GeneOntologyBiologicalProcess	cardiac muscle tissue development	MET HCN4 PDGFRB WNT2 RBM10 FRS2 IRX3 RYR2	1.16e-04	327	93	8	GO:0048738
GeneOntologyBiologicalProcess	cell surface receptor protein tyrosine kinase signaling pathway	MET NRXN1 PILRB PDGFRB PIK3R2 FRS3 FRS2 ADGRE4P PIP4K2B GIGYF1 MMP9 PHIP	1.32e-04	747	93	12	GO:0007169
GeneOntologyBiologicalProcess	heart development	MET PDE2A HCN4 ADAMTS6 PDGFRB WNT2 RBM10 FRS2 IRX3 MMP9 RYR2 PCNA	1.50e-04	757	93	12	GO:0007507
GeneOntologyBiologicalProcess	striated muscle tissue development	MET HCN4 PDGFRB WNT2 RBM10 FRS2 IRX3 RYR2	1.81e-04	349	93	8	GO:0014706
GeneOntologyBiologicalProcess	presynaptic active zone assembly	NRXN1 BSN	1.99e-04	5	93	2	GO:1904071
GeneOntologyCellularComponent	HCN channel complex	HCN4 HCN3	1.19e-04	4	94	2	GO:0098855
Domain	-	MET LLGL2 DCAF8 BBS1 WDR76 PHIP BRWD3 PLXNB1 DCAF12	3.55e-05	333	91	9	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	MET LLGL2 DCAF8 BBS1 WDR76 PHIP BRWD3 PLXNB1 DCAF12	3.72e-05	335	91	9	IPR015943
Domain	DER1	DERL3 DERL2	7.02e-05	3	91	2	IPR007599
Domain	ConA-like_dom	FSD1L NRXN3 NRXN1 BTN1A1 HNRNPUL1 RYR2 CRB1	9.73e-05	219	91	7	IPR013320
Domain	ASX_HYDROXYL	NRXN3 HMCN2 NRXN1 ADGRE4P CRB1	1.29e-04	100	91	5	PS00010
Domain	Ion_trans_N	HCN4 HCN3	1.40e-04	4	91	2	PF08412
Domain	Ion_trans_N	HCN4 HCN3	1.40e-04	4	91	2	IPR013621
Domain	EGF-type_Asp/Asn_hydroxyl_site	NRXN3 HMCN2 NRXN1 ADGRE4P CRB1	1.69e-04	106	91	5	IPR000152
Domain	ADAM_spacer1	ADAMTS6 ADAMTS20 PAPLN	1.85e-04	23	91	3	IPR010294
Domain	ADAM_spacer1	ADAMTS6 ADAMTS20 PAPLN	1.85e-04	23	91	3	PF05986
Domain	Peptidase_M12B_ADAM-TS	ADAMTS6 ADAMTS20 PAPLN	2.10e-04	24	91	3	IPR013273
Domain	Ig_I-set	SIGLEC12 HMCN2 PDGFRB OBSCN PAPLN IGSF9B	3.33e-04	190	91	6	IPR013098
Domain	I-set	SIGLEC12 HMCN2 PDGFRB OBSCN PAPLN IGSF9B	3.33e-04	190	91	6	PF07679
Domain	Ig_V-set	SIGLEC12 PILRB BTN1A1 OBSCN PAPLN IGSF9B	4.27e-04	199	91	6	IPR013106
Domain	Syndecan	NRXN3 NRXN1	4.85e-04	7	91	2	PF01034
Domain	Syndecan/Neurexin_dom	NRXN3 NRXN1	4.85e-04	7	91	2	IPR027789
Domain	IGv	BTN1A1 OBSCN PAPLN IGSF9B	4.92e-04	75	91	4	SM00406
Domain	Ig-like_fold	SIGLEC12 MET FSD1L HMCN2 PILRB PDGFRB BTN1A1 OBSCN PAPLN IGSF9B PLXNB1	6.30e-04	706	91	11	IPR013783
Domain	LAM_G_DOMAIN	NRXN3 NRXN1 CRB1	8.34e-04	38	91	3	PS50025
Domain	SPRY	FSD1L BTN1A1 HNRNPUL1 RYR2	8.62e-04	87	91	4	SM00449
Domain	Laminin_G_2	NRXN3 NRXN1 CRB1	9.70e-04	40	91	3	PF02210
Domain	IGc2	SIGLEC12 HMCN2 PDGFRB OBSCN PAPLN IGSF9B	1.02e-03	235	91	6	SM00408
Domain	EGF_3	STAB2 NRXN3 HMCN2 NRXN1 ADGRE4P CRB1	1.02e-03	235	91	6	PS50026
Domain	Ig_sub2	SIGLEC12 HMCN2 PDGFRB OBSCN PAPLN IGSF9B	1.02e-03	235	91	6	IPR003598
Domain	IG	SIGLEC12 HMCN2 PILRB PDGFRB BTN1A1 OBSCN PAPLN IGSF9B	1.04e-03	421	91	8	SM00409
Domain	Ig_sub	SIGLEC12 HMCN2 PILRB PDGFRB BTN1A1 OBSCN PAPLN IGSF9B	1.04e-03	421	91	8	IPR003599
Domain	SPRY	FSD1L BTN1A1 HNRNPUL1 RYR2	1.15e-03	94	91	4	PF00622
Domain	SPRY_dom	FSD1L BTN1A1 HNRNPUL1 RYR2	1.15e-03	94	91	4	IPR003877
Domain	B30.2/SPRY	FSD1L BTN1A1 HNRNPUL1 RYR2	1.20e-03	95	91	4	IPR001870
Domain	B302_SPRY	FSD1L BTN1A1 HNRNPUL1 RYR2	1.20e-03	95	91	4	PS50188
Domain	PTBI	FRS3 FRS2	1.25e-03	11	91	2	SM00310
Domain	LamG	NRXN3 NRXN1 CRB1	1.28e-03	44	91	3	SM00282
Domain	PROTEIN_KINASE_TYR	MET CSK PDGFRB OBSCN	1.29e-03	97	91	4	PS00109
Domain	Tyr_kinase_AS	MET CSK PDGFRB OBSCN	1.29e-03	97	91	4	IPR008266
Domain	EGF-like_dom	STAB2 NRXN3 HMCN2 NRXN1 ADGRE4P CRB1	1.37e-03	249	91	6	IPR000742
Domain	-	SIGLEC12 MET FSD1L PILRB PDGFRB BTN1A1 OBSCN PAPLN IGSF9B PLXNB1	1.43e-03	663	91	10	2.60.40.10
Domain	IRS_PTB	FRS3 FRS2	1.50e-03	12	91	2	PS51064
Domain	WD40	LLGL2 DCAF8 WDR76 PHIP BRWD3 DCAF12	1.67e-03	259	91	6	PF00400
Domain	-	MRC2 MMP9	1.77e-03	13	91	2	2.10.10.10
Domain	WD40	LLGL2 DCAF8 WDR76 PHIP BRWD3 DCAF12	1.99e-03	268	91	6	SM00320
Domain	IRS_PTB	FRS3 FRS2	2.06e-03	14	91	2	IPR002404
Domain	FN_type2_col-bd	MRC2 MMP9	2.06e-03	14	91	2	IPR000562
Domain	FN2_2	MRC2 MMP9	2.06e-03	14	91	2	PS51092
Domain	PLAC	ADAMTS6 PAPLN	2.06e-03	14	91	2	PF08686
Domain	K_chnl_volt-dep_EAG/ELK/ERG	HCN4 HCN3	2.06e-03	14	91	2	IPR003938
Domain	fn2	MRC2 MMP9	2.06e-03	14	91	2	PF00040
Domain	FN2_1	MRC2 MMP9	2.06e-03	14	91	2	PS00023
Domain	FN2	MRC2 MMP9	2.06e-03	14	91	2	SM00059
Domain	Neurexin-like	NRXN3 NRXN1	2.06e-03	14	91	2	IPR003585
Domain	4.1m	NRXN3 NRXN1	2.06e-03	14	91	2	SM00294
Domain	IRS	FRS3 FRS2	2.06e-03	14	91	2	PF02174
Domain	WD40_repeat	LLGL2 DCAF8 WDR76 PHIP BRWD3 DCAF12	2.14e-03	272	91	6	IPR001680
Domain	WD_REPEATS_1	LLGL2 DCAF8 WDR76 PHIP BRWD3 DCAF12	2.39e-03	278	91	6	PS00678
Domain	WD_REPEATS_2	LLGL2 DCAF8 WDR76 PHIP BRWD3 DCAF12	2.43e-03	279	91	6	PS50082
Domain	WD_REPEATS_REGION	LLGL2 DCAF8 WDR76 PHIP BRWD3 DCAF12	2.43e-03	279	91	6	PS50294
Domain	IG_LIKE	SIGLEC12 HMCN2 PILRB PDGFRB BTN1A1 OBSCN PAPLN IGSF9B	2.72e-03	491	91	8	PS50835
Domain	Laminin_G	NRXN3 NRXN1 CRB1	2.84e-03	58	91	3	IPR001791
Domain	Ig-like_dom	SIGLEC12 HMCN2 PILRB PDGFRB BTN1A1 OBSCN PAPLN IGSF9B	3.15e-03	503	91	8	IPR007110
Domain	EGF-like_Ca-bd_dom	STAB2 HMCN2 ADGRE4P CRB1	3.17e-03	124	91	4	IPR001881
Domain	WD40_repeat_dom	LLGL2 DCAF8 WDR76 PHIP BRWD3 DCAF12	3.31e-03	297	91	6	IPR017986
Domain	EGF	STAB2 NRXN3 NRXN1 CRB1	3.36e-03	126	91	4	PF00008
Domain	TSP_1	ADAMTS6 ADAMTS20 PAPLN	3.60e-03	63	91	3	PF00090
Domain	Wnt	WNT2 WNT7B	3.80e-03	19	91	2	IPR005817
Domain	PLAC	ADAMTS6 PAPLN	3.80e-03	19	91	2	PS50900
Domain	Wnt_CS	WNT2 WNT7B	3.80e-03	19	91	2	IPR018161
Domain	wnt	WNT2 WNT7B	3.80e-03	19	91	2	PF00110
Domain	PLAC	ADAMTS6 PAPLN	3.80e-03	19	91	2	IPR010909
Domain	WNT1	WNT2 WNT7B	3.80e-03	19	91	2	SM00097
Domain	WNT1	WNT2 WNT7B	3.80e-03	19	91	2	PS00246
Domain	TSP1	ADAMTS6 ADAMTS20 PAPLN	3.93e-03	65	91	3	SM00209
Domain	TSP1_rpt	ADAMTS6 ADAMTS20 PAPLN	3.93e-03	65	91	3	IPR000884
Domain	TSP1	ADAMTS6 ADAMTS20 PAPLN	3.93e-03	65	91	3	PS50092
Domain	CRAL_TRIO	PTPN9 ARHGAP8	4.64e-03	21	91	2	PF00650
Pubmed	PIKES Analysis Reveals Response to Degraders and Key Regulatory Mechanisms of the CRL4 Network.	DCAF8 PIP4K2B PHIP BRWD3 DCAF12	2.37e-07	49	95	5	31973889
Pubmed	Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery.	DCAF8 PHIP PCNA DCAF12	1.77e-06	32	95	4	16964240
Pubmed	Neurexin-3 subsynaptic densities are spatially distinct from Neurexin-1 and essential for excitatory synapse nanoscale organization in the hippocampus.	NRXN3 NRXN1	7.38e-06	2	95	2	37543682
Pubmed	Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action.	NRXN3 NRXN1	7.38e-06	2	95	2	9430716
Pubmed	Direct interaction between mammalian DNA polymerase beta and proliferating cell nuclear antigen.	POLB PCNA	7.38e-06	2	95	2	12063248
Pubmed	Human DNA polymerase β, but not λ, can bypass a 2-deoxyribonolactone lesion together with proliferating cell nuclear antigen.	POLB PCNA	7.38e-06	2	95	2	23101935
Pubmed	FRS2 family docking proteins with overlapping roles in activation of MAP kinase have distinct spatial-temporal patterns of expression of their transcripts.	FRS3 FRS2	7.38e-06	2	95	2	15094036
Pubmed	Phenotype/Genotype Relationship in Left Ventricular Noncompaction: Ion Channel Gene Mutations Are Associated With Preserved Left Ventricular Systolic Function and Biventricular Noncompaction: Phenotype/Genotype of Noncompaction.	HCN4 RYR2	7.38e-06	2	95	2	34088380
Pubmed	Molecular cloning and localization to chromosome 6 of mouse INT1L1 gene.	MET WNT2	7.38e-06	2	95	2	2531931
Pubmed	Association of a polymorphism in the NRXN3 gene with the degree of smoking in schizophrenia: a preliminary study.	NRXN3 NRXN1	7.38e-06	2	95	2	19658047
Pubmed	Broadly expressed SNT-like proteins link FGF receptor stimulation to activators of Ras.	FRS3 FRS2	7.38e-06	2	95	2	8761293
Pubmed	[Study of gastric carcinoma and PCNA and c-met gene abnormality].	MET PCNA	7.38e-06	2	95	2	18839537
Pubmed	Proliferating cell nuclear antigen binds DNA polymerase-β and mediates 1-methyl-4-phenylpyridinium-induced neuronal death.	POLB PCNA	7.38e-06	2	95	2	25184665
Pubmed	The signaling adapters fibroblast growth factor receptor substrate 2 and 3 are activated by the thyroid TRK oncoproteins.	FRS3 FRS2	7.38e-06	2	95	2	12586769
Pubmed	c-Met identifies a population of matrix metalloproteinase 9-producing monocytes in peritumoural stroma of hepatocellular carcinoma.	MET MMP9	7.38e-06	2	95	2	26108200
Pubmed	Co-expression of plexin-B1 and Met in human breast and ovary tumours enhances the risk of progression.	MET PLXNB1	7.38e-06	2	95	2	19940359
Pubmed	6-Phosphogluconate dehydrogenase regulates tumor cell migration in vitro by regulating receptor tyrosine kinase c-Met.	MET PGD	7.38e-06	2	95	2	23973484
Pubmed	Identification of multiple SNT-binding sites on NPM-ALK oncoprotein and their involvement in cell transformation.	FRS3 FRS2	7.38e-06	2	95	2	17086210
Pubmed	Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site.	RBM10 NUMB	7.38e-06	2	95	2	25889998
Pubmed	Plexin B1 suppresses c-Met in melanoma: a role for plexin B1 as a tumor-suppressor protein through regulation of c-Met.	MET PLXNB1	7.38e-06	2	95	2	20164843
Pubmed	Neurotrophin and FGF Signaling Adapter Proteins, FRS2 and FRS3, Regulate Dentate Granule Cell Maturation and Excitatory Synaptogenesis.	FRS3 FRS2	7.38e-06	2	95	2	29155277
Pubmed	Nucleotide sequence, chromosomal localization and developmental expression of the mouse int-1-related gene.	MET WNT2	7.38e-06	2	95	2	2693041
Pubmed	Genomic organization and comparative sequence analysis of the mouse and human FRS2, FRS3 genes.	FRS3 FRS2	7.38e-06	2	95	2	12688531
Pubmed	Large-scale structural analysis of the classical human protein tyrosine phosphatome.	MET PTPN9 CSK PDGFRB	8.51e-06	47	95	4	19167335
Pubmed	CRL4DCAF8 and USP11 oppositely regulate the stability of myeloid leukemia factors (MLFs).	DCAF8 WDR76 PCNA	1.08e-05	16	95	3	32703400
Pubmed	Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease.	PDGFRB WNT2 MMP9 PCNA	1.28e-05	52	95	4	30389913
Pubmed	Wnt2 signaling is necessary and sufficient to activate the airway smooth muscle program in the lung by regulating myocardin/Mrtf-B and Fgf10 expression.	PDGFRB WNT2 WNT7B	1.31e-05	17	95	3	21704027
Pubmed	An FGF-WNT gene regulatory network controls lung mesenchyme development.	WNT2 WNT7B PCNA	1.31e-05	17	95	3	18533146
Pubmed	An interaction network of the mammalian COP9 signalosome identifies Dda1 as a core subunit of multiple Cul4-based E3 ligases.	DCAF8 KLHL12 PHIP DCAF12	2.12e-05	59	95	4	19295130
Pubmed	Conditional Knockout of Neurexins Alters the Contribution of Calcium Channel Subtypes to Presynaptic Ca2+ Influx.	NRXN3 NRXN1	2.21e-05	3	95	2	38891114
Pubmed	XRCC1 co-localizes and physically interacts with PCNA.	POLB PCNA	2.21e-05	3	95	2	15107487
Pubmed	Calycosin down-regulates c-Met to suppress development of glioblastomas.	MET MMP9	2.21e-05	3	95	2	31502574
Pubmed	Prominent expression of FRS2beta protein in neural cells and its association with intracellular vesicles.	FRS3 FRS2	2.21e-05	3	95	2	19187780
Pubmed	alpha-Neurexins are required for efficient transmitter release and synaptic homeostasis at the mouse neuromuscular junction.	NRXN3 NRXN1	2.21e-05	3	95	2	16406382
Pubmed	Accumulation of non-outer segment proteins in the outer segment underlies photoreceptor degeneration in Bardet-Biedl syndrome.	BBS1 CRB1	2.21e-05	3	95	2	26216965
Pubmed	UNC-51-like kinase regulation of fibroblast growth factor receptor substrate 2/3.	FRS3 FRS2	2.21e-05	3	95	2	16887332
Pubmed	Alternative Splicing of Presynaptic Neurexins Differentially Controls Postsynaptic NMDA and AMPA Receptor Responses.	NRXN3 NRXN1	2.21e-05	3	95	2	31005376
Pubmed	The human Lgl polarity gene, Hugl-2, induces MET and suppresses Snail tumorigenesis.	MET LLGL2	2.21e-05	3	95	2	22580609
Pubmed	Dopaminergic neurons establish a distinctive axonal arbor with a majority of non-synaptic terminals.	NRXN1 BSN	2.21e-05	3	95	2	34320240
Pubmed	Sema4D induces angiogenesis through Met recruitment by Plexin B1.	MET PLXNB1	2.21e-05	3	95	2	15632204
Pubmed	HIV gp120 binds to mannose receptor on vaginal epithelial cells and induces production of matrix metalloproteinases.	MRC2 MMP9	2.21e-05	3	95	2	22132194
Pubmed	Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals.	NRXN3 NRXN1	2.21e-05	3	95	2	26446217
Pubmed	Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity.	NRXN3 NRXN1	2.21e-05	3	95	2	11944992
Pubmed	The semaphorin 4D receptor controls invasive growth by coupling with Met.	MET PLXNB1	2.21e-05	3	95	2	12198496
Pubmed	Alternative splicing of neurexins 1-3 is modulated by neuroinflammation in the prefrontal cortex of a murine model of multiple sclerosis.	NRXN3 NRXN1	2.21e-05	3	95	2	33058888
Pubmed	Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules.	NRXN3 NRXN1	2.21e-05	3	95	2	17035546
Pubmed	Neurexins: three genes and 1001 products.	NRXN3 NRXN1	2.21e-05	3	95	2	9448462
Pubmed	Deletion of α-neurexin II results in autism-related behaviors in mice.	NRXN3 NRXN1	2.21e-05	3	95	2	25423136
Pubmed	Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior.	NRXN3 NRXN1	2.21e-05	3	95	2	34133920
Pubmed	The within-subject application of diffusion tensor MRI and CLARITY reveals brain structural changes in Nrxn2 deletion mice.	NRXN3 NRXN1	2.21e-05	3	95	2	30858964
Pubmed	Neurexins 1-3 Each Have a Distinct Pattern of Expression in the Early Developing Human Cerebral Cortex.	NRXN3 NRXN1	2.21e-05	3	95	2	28013231
Pubmed	Direct interaction of Rnd1 with FRS2 beta regulates Rnd1-induced down-regulation of RhoA activity and is involved in fibroblast growth factor-induced neurite outgrowth in PC12 cells.	FRS3 FRS2	2.21e-05	3	95	2	15738000
Pubmed	Ketamine Restores Thalamic-Prefrontal Cortex Functional Connectivity in a Mouse Model of Neurodevelopmental Disorder-Associated 2p16.3 Deletion.	NRXN3 NRXN1	2.21e-05	3	95	2	31812984
Pubmed	Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing.	NRXN3 NRXN1	2.21e-05	3	95	2	12036300
Pubmed	β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling.	NRXN3 NRXN1	2.21e-05	3	95	2	26213384
Pubmed	Neurexin gene family variants as risk factors for autism spectrum disorder.	NRXN3 NRXN1	2.21e-05	3	95	2	29045040
Pubmed	FRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expression.	PDGFRB FRS2	2.21e-05	3	95	2	19339244
Pubmed	Structural and functional characterization of the IgSF21-neurexin2α complex and its related signaling pathways in the regulation of inhibitory synapse organization.	NRXN3 NRXN1	2.21e-05	3	95	2	38571813
Pubmed	Deletion of β-Neurexins in Mice Alters the Distribution of Dense-Core Vesicles in Presynapses of Hippocampal and Cerebellar Neurons.	NRXN3 NRXN1	2.21e-05	3	95	2	35173587
Pubmed	HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death.	MET PDGFRB	2.21e-05	3	95	2	8947043
Pubmed	FRS2 PTB domain conformation regulates interactions with divergent neurotrophic receptors.	FRS3 FRS2	2.21e-05	3	95	2	11877385
Pubmed	Fibroblast growth factor receptor 1 (FGFR1) tyrosine phosphorylation regulates binding of FGFR substrate 2alpha (FRS2alpha) but not FRS2 to the receptor.	FRS3 FRS2	2.21e-05	3	95	2	17901128
Pubmed	Neurexins are differentially expressed in the embryonic nervous system of mice.	NRXN3 NRXN1	2.21e-05	3	95	2	7722633
Pubmed	Transactivation of Met signalling by semaphorin4D in human placenta: implications for the pathogenesis of preeclampsia.	MET PLXNB1	2.21e-05	3	95	2	29939944
Pubmed	Genomic, epigenomic, and biophysical cues controlling the emergence of the lung alveolus.	PDGFRB WNT2 WNT7B	3.36e-05	23	95	3	33707239
Pubmed	Hedgehog signalling controls sinoatrial node development and atrioventricular cushion formation.	HCN4 WNT2 RYR2	3.83e-05	24	95	3	34062094
Pubmed	Functional expression of the human HCN3 channel.	HCN4 HCN3	4.41e-05	4	95	2	16043489
Pubmed	Leucine aminopeptidase 3 promotes migration and invasion of breast cancer cells through upregulation of fascin and matrix metalloproteinases-2/9 expression.	MMP9 FSCN1	4.41e-05	4	95	2	30417585
Pubmed	Deorphanizing FAM19A proteins as pan-neurexin ligands with an unusual biosynthetic binding mechanism.	NRXN3 NRXN1	4.41e-05	4	95	2	32706374
Pubmed	Interactive cloning with the SH3 domain of N-src identifies a new brain specific ion channel protein, with homology to eag and cyclic nucleotide-gated channels.	HCN4 HCN3	4.41e-05	4	95	2	9405696
Pubmed	Role of subunit heteromerization and N-linked glycosylation in the formation of functional hyperpolarization-activated cyclic nucleotide-gated channels.	HCN4 HCN3	4.41e-05	4	95	2	12928435
Pubmed	A membrane protein required for dislocation of misfolded proteins from the ER.	DERL3 DERL2	4.41e-05	4	95	2	15215855
Pubmed	R152C DNA Pol β mutation impairs base excision repair and induces cellular transformation.	POLB PCNA	4.41e-05	4	95	2	26760506
Pubmed	Hyperpolarization-activated and cyclic nucleotide-gated channels are differentially expressed in juxtaglomerular cells in the olfactory bulb of mice.	HCN4 HCN3	4.41e-05	4	95	2	20140458
Pubmed	Investigation of hyperpolarization-activated cyclic nucleotide-gated channels in interstitial cells of Cajal of human bladder.	HCN4 HCN3	4.41e-05	4	95	2	22748890
Pubmed	Genetic variations in ATP2B1, CSK, ARSG and CSMD1 loci are related to blood pressure and/or hypertension in two Korean cohorts.	CSK CSMD1	4.41e-05	4	95	2	19960030
Pubmed	CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent protein kinase domain identified by interaction with neurexins.	NRXN3 NRXN1	4.41e-05	4	95	2	8786425
Pubmed	Deletion of alpha-neurexins does not cause a major impairment of axonal pathfinding or synapse formation.	NRXN3 NRXN1	4.41e-05	4	95	2	17347997
Pubmed	Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain.	HCN4 HCN3	4.41e-05	4	95	2	9630217
Pubmed	Expression of CD147, PCNA, VEGF, MMPs and their clinical significance in the giant cell tumor of bones.	MMP9 PCNA	4.41e-05	4	95	2	26339416
Pubmed	Neurexins play a crucial role in cerebellar granule cell survival by organizing autocrine machinery for neurotrophins.	NRXN3 NRXN1	4.41e-05	4	95	2	35385735
Pubmed	Neurexins regulate presynaptic GABAB-receptors at central synapses.	NRXN3 NRXN1	4.41e-05	4	95	2	33888718
Pubmed	Identification of TMPRSS2-ERG mechanisms in prostate cancer invasiveness: Involvement of MMP-9 and plexin B1.	MMP9 PLXNB1	4.41e-05	4	95	2	28004109
Pubmed	Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins.	NRXN3 NRXN1	4.41e-05	4	95	2	14983056
Pubmed	RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation.	RBM10 NUMB	4.41e-05	4	95	2	24332178
Pubmed	Derlin-3 Is Required for Changes in ERAD Complex Formation under ER Stress.	DERL3 DERL2	4.41e-05	4	95	2	32858914
Pubmed	GluRδ2 assembles four neurexins into trans-synaptic triad to trigger synapse formation.	NRXN1 BSN	4.41e-05	4	95	2	22457515
Pubmed	Replication protein A and proliferating cell nuclear antigen coordinate DNA polymerase selection in 8-oxo-guanine repair.	POLB PCNA	4.41e-05	4	95	2	19104052
Pubmed	Genetic analysis of hyperpolarization-activated cyclic nucleotide-gated cation channels in sudden unexpected death in epilepsy cases.	HCN4 HCN3	4.41e-05	4	95	2	21615589
Pubmed	DNA polymerases beta and lambda bypass thymine glycol in gapped DNA structures.	POLB PCNA	4.41e-05	4	95	2	20423048
Pubmed	TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade.	BSN GRM6	4.41e-05	4	95	2	19966281
Pubmed	A genomic clone containing a telomere array maps near the centromere of mouse chromosome 6.	MET WNT2	4.41e-05	4	95	2	7767012
Pubmed	Developmental expression patterns of the signaling adapters FRS-2 and FRS-3 during early embryogenesis.	FRS3 FRS2	4.41e-05	4	95	2	11335123
Pubmed	Effect of cancer-associated mutations in the PlexinB1 gene.	MET PLXNB1	4.41e-05	4	95	2	22404908
Pubmed	Neurexins cluster Ca2+ channels within the presynaptic active zone.	NRXN3 NRXN1	4.41e-05	4	95	2	32134527
Pubmed	ErbB-2 and met reciprocally regulate cellular signaling via plexin-B1.	MET PLXNB1	4.41e-05	4	95	2	18025083
Pubmed	Viable hypomorphic signaling mutant of the Met receptor reveals a role for hepatocyte growth factor in postnatal cerebellar development.	MET PCNA	4.41e-05	4	95	2	12397180
Pubmed	Novel recognition motif on fibroblast growth factor receptor mediates direct association and activation of SNT adapter proteins.	FRS3 FRS2	4.41e-05	4	95	2	9660748
Pubmed	O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.	ADAMTS6 ADAMTS20 PAPLN MMP9	5.47e-05	75	95	4	20637190
Pubmed	Activation of PI3K/p110α in the Lung Mesenchyme Affects Branching Morphogenesis and Club Cell Differentiation.	WNT2 WNT7B PCNA	6.16e-05	28	95	3	35676931
Cytoband	14q31	NRXN3 GPR68	1.51e-04	9	95	2	14q31
Cytoband	9q31	FSD1L UGCG	5.65e-04	17	95	2	9q31
Cytoband	16q12.2	CHD9 IRX3	1.33e-03	26	95	2	16q12.2
Cytoband	Ensembl 112 genes in cytogenetic band chr15q24	PTPN9 HCN4 CSK	2.12e-03	122	95	3	chr15q24
Cytoband	15q24.1	HCN4 CSK	2.28e-03	34	95	2	15q24.1
Cytoband	12q23.3	STAB2 WSCD2	2.41e-03	35	95	2	12q23.3
Cytoband	9q33.3	OLFML2A GARNL3	2.69e-03	37	95	2	9q33.3
Cytoband	Ensembl 112 genes in cytogenetic band chr7p22	DAGLB USP42 FSCN1	2.77e-03	134	95	3	chr7p22
Cytoband	Ensembl 112 genes in cytogenetic band chr9q31	FSD1L DNAJC25 UGCG	2.94e-03	137	95	3	chr9q31
Cytoband	7p22.1	DAGLB USP42	4.31e-03	47	95	2	7p22.1
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	SIGLEC12 HMCN2 PDGFRB OBSCN PAPLN IGSF9B	3.43e-05	161	69	6	593
GeneFamily	WD repeat domain containing\|DDB1 and CUL4 associated factors	DCAF8 PHIP DCAF12	4.17e-05	18	69	3	498
GeneFamily	WD repeat domain containing	LLGL2 DCAF8 WDR76 PHIP BRWD3 DCAF12	4.88e-04	262	69	6	362
GeneFamily	Cyclic nucleotide gated channels	HCN4 HCN3	6.33e-04	10	69	2	250
GeneFamily	Rhomboid family	DERL3 DERL2	1.27e-03	14	69	2	926
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS6 ADAMTS20	2.35e-03	19	69	2	50
GeneFamily	Wnt family\|Endogenous ligands	WNT2 WNT7B	2.35e-03	19	69	2	360
GeneFamily	Adenosine receptors\|V-set domain containing	SIGLEC12 PILRB BTN1A1 IGSF9B	3.49e-03	163	69	4	590
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	NRXN3 NRXN1 PILRB AP3B2 HCN3 UGCG FRS3 PIP4K2B IGSF9B IRX3 GIGYF1 CSMD1 BSN ADCY1 RYR2	8.89e-06	1106	94	15	M39071
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_100	WNT2 FSCN1 CRHBP RYR2	1.23e-05	33	92	4	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100_k1
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA5B2 NRXN3 FBXO41 CSMD1 BSN ADCY1 RYR2	1.93e-07	193	95	7	be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA5B2 NRXN3 FBXO41 CSMD1 BSN ADCY1 RYR2	1.93e-07	193	95	7	0c652ebe22ce5d2927599dd97ef1920547858395
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA5B2 NRXN3 FBXO41 CSMD1 BSN ADCY1 RYR2	1.93e-07	193	95	7	8689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 CRYBA2 HCN4 AP3B2 BSN ADCY1	2.01e-06	174	95	6	a62531ebf16b32b249168dca11b870f63a8aa81c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	OLFML2A HMCN2 ITPRIP FSCN1 ADCY1 CRHBP	2.14e-06	176	95	6	64e426f5e84884ce2c29acf6f4b958962a63927f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 NRXN1 OBSCN ADAMTS20 CSMD1 RYR2	2.77e-06	184	95	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 NRXN1 OBSCN ADAMTS20 CSMD1 RYR2	2.77e-06	184	95	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 NRXN1 OBSCN ADAMTS20 CSMD1 RYR2	2.77e-06	184	95	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Endothelial_cells-Endothelial-B\|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id	OLFML2A DENND2A PDE2A STAB2 PAPLN FSCN1	3.99e-06	196	95	6	36f95f9ef74eb951e41ef46fd136ceaef45208fc
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FSD1L LLGL2 NRXN3 PHIP PLXNB1 CRB1	4.11e-06	197	95	6	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PKIG DENND2A GARNL3 PDGFRB IGSF9B RYR2	4.35e-06	199	95	6	b768496381362f9a2706e0892b5a7a0db82e09ce
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	VWA5B2 NRXN1 HCN4 AP3B2 BSN	2.32e-05	159	95	5	7747cef94c55144fddcd024a7495318357f1351b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FSCN1 WDR76 CRHBP PCNA RAVER1	2.39e-05	160	95	5	830e3ef8c9708d25872c3052a0b2682fa9372111
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND2A STAB2 C17orf99 DERL3 BTN1A1	2.46e-05	161	95	5	60f433eab9d5531bdf6aa86b0265f20b866b904c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRSS55 IGSF9B IRX3 FSCN1 PCNA	2.61e-05	163	95	5	bb09e6ca3406eee0593d9a312db7e05934309dd2
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRYBA2 NRXN1 DEFB104A IGSF9B CSMD1	2.69e-05	164	95	5	3caf4cdaa0164907893fea61e251fd8b5fa926e4
ToppCell	facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBMXL2 NRXN3 PRSS55 CSMD1 RYR2	2.77e-05	165	95	5	6d315e0734079ad05336cc2c3f24d870c9105bc8
ToppCell	facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBMXL2 NRXN3 PRSS55 CSMD1 RYR2	2.77e-05	165	95	5	84f5597b1bb75f42de9a224196bb8ac198bbe3bf
ToppCell	Endothelial-B-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	OLFML2A DENND2A PDE2A STAB2 FSCN1	3.11e-05	169	95	5	95c617143e1fbdd1d55a93ffdcc210e0be37cf2f
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IMPA2 NRXN1 PDGFRB PAPLN RYR2	3.20e-05	170	95	5	5570c0e825bca77613bf0ebde620cf744fa1cb84
ToppCell	Endothelial-B-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	OLFML2A DENND2A PDE2A STAB2 FSCN1	3.29e-05	171	95	5	07ff7059071da83da1d8f266a586573920d75b58
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 CRYBA2 HCN4 BSN ADCY1	3.47e-05	173	95	5	07798461d12d04f3dabff03481c999cb07c5af2f
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 CRYBA2 LLGL2 AP3B2 ADCY1	3.47e-05	173	95	5	46ed379571385684145b5cb6dd4ae340ac546e64
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRXN1 HCN4 IGSF9B BSN CRHBP	3.57e-05	174	95	5	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DENND2A PDGFRB UGCG CSMD1 RYR2	3.57e-05	174	95	5	015d3742d3d79a57413a333f00ef2d380a9848dd
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 CRYBA2 HCN4 AP3B2 BSN	3.77e-05	176	95	5	2e1003dc373b14d27f0464d980453fdcfc1005f0
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IMPA2 DERL3 DNPH1 WDR76 PCNA	3.77e-05	176	95	5	9e719e6323597ecfc758c957256872cd4ae24d4d
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PKIG DENND2A WSCD2 IGSF9B RYR2	3.98e-05	178	95	5	8ec2a25dda96c9cc9c2904b6cb18f75a293f4969
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PKIG DENND2A WSCD2 IGSF9B RYR2	3.98e-05	178	95	5	6c91331196696e0cf239d105f458e3230659fa38
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231\|Adult / Lineage, Cell type, age group and donor	OLFML2A DENND2A PDE2A STAB2 FSCN1	3.98e-05	178	95	5	c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA5B2 CRYBA2 NRXN1 HCN4 AP3B2	3.98e-05	178	95	5	30ca37f70d267cc9b40ca3e211f16d30360c3e6b
ToppCell	3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 CRYBA2 RBMXL2 LLGL2 HCN4	4.20e-05	180	95	5	d553aba594f5304f1c09ff9c6d49b64cd7ee7850
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MET FSD1L NRXN3 IMPA2 IRX3	4.20e-05	180	95	5	b798a3fa2dd15b68aa4267f665559527043dcc07
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDE2A STAB2 IGSF9B BSN FSCN1	4.31e-05	181	95	5	b0fff0defba9aea6fba36e378b05a59986e2573a
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	OLFML2A PDE2A STAB2 ADAMTS20 FSCN1	4.31e-05	181	95	5	e898ecb8d8f2eb2204225b7b0d665cadcd241139
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDE2A STAB2 IGSF9B BSN FSCN1	4.31e-05	181	95	5	cc77ac0e223e012767222e45c5dcadc246d1aa7c
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDE2A STAB2 IGSF9B BSN FSCN1	4.31e-05	181	95	5	ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa
ToppCell	Epithelial-lung_neuroendocrine_cell_(PNEC)\|World / Lineage, Cell type, age group and donor	VWA5B2 NRXN1 HCN4 AP3B2 BSN	4.42e-05	182	95	5	57bf4ffb304324e2e392e196336a530d9f78fe0d
ToppCell	E12.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LLGL2 WNT7B DUSP9 IRX3 ARHGAP8	4.42e-05	182	95	5	204530444e35d4977a7239ac176f477e9e5c29ab
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NRXN1 AP3B2 WDR76 PCNA CRB1	4.42e-05	182	95	5	e6968e0bd9cef92052d04ac54e2dd746b37623f6
ToppCell	wk_15-18-Epithelial-PNS-intermediate_Schwann\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	OLFML2A NRXN3 FSTL3 NRXN1 IGSF9B	4.54e-05	183	95	5	d874aa9a856f79626c8a8371f6196a77b7d662ee
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DENND2A NRXN1 PDGFRB PAPLN RYR2	4.54e-05	183	95	5	8a799807fbf24456a9811e0c64068187940a2f71
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MET FSD1L NRXN3 IMPA2 IRX3	4.54e-05	183	95	5	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DENND2A NRXN1 PDGFRB PAPLN RYR2	4.66e-05	184	95	5	689a8af81a79a4bb3123cfa01958c953eab5de98
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRYBA2 NRXN1 HCN4 AP3B2 ADCY1	4.66e-05	184	95	5	e0e5a553fb8c0947679634396d20c2ca8455b932
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRYBA2 NRXN1 HCN4 AP3B2 ADCY1	4.66e-05	184	95	5	c3b848e1438a84b3fac8a4e40f3db478cc84d970
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKIG FSTL3 WSCD2 GRM6	4.72e-05	93	95	4	096a207dfd280b23480bc068a15e6947423620c5
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKIG FSTL3 WSCD2 GRM6	4.72e-05	93	95	4	6977ae7eccb45fbc48960a0945be9ccc7566ca8b
ToppCell	droplet-Lung-immune-endo-depleted-3m-Epithelial-lung_neuroendocrine_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRYBA2 NRXN1 HCN4 AP3B2 ADCY1	4.78e-05	185	95	5	30263c558ee331e0879abcf8b4c2427ff05f9fe7
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DENND2A NRXN3 IMPA2 PDGFRB RYR2	4.78e-05	185	95	5	a7dba7db79275884b2a93d8a16f2e0c739e71370
ToppCell	Endothelial-B-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	OLFML2A DENND2A PDE2A STAB2 FSCN1	4.78e-05	185	95	5	133c9dc64d564dae4aeeeca22f386aa3f13fa980
ToppCell	droplet-Lung-immune-endo-depleted-3m-Epithelial-Neuroendocrine\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRYBA2 NRXN1 HCN4 AP3B2 ADCY1	4.78e-05	185	95	5	1b000ca11970db8f347eb97ff44605d562aea70a
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRB MRC2 WNT2 PAPLN RYR2	4.91e-05	186	95	5	5473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA5B2 FBXO41 CSMD1 BSN RYR2	4.91e-05	186	95	5	7278a1a1bf9bb27aeb03852134defb31b62f30d6
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	OLFML2A DENND2A PDE2A ADAMTS20 FSCN1	4.91e-05	186	95	5	20340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Pulmonary_neuroendocrine\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	VWA5B2 NRXN1 HCN4 AP3B2 ADCY1	4.91e-05	186	95	5	fcabebdfbf1b1dbb35ce2b3c53a60d2b1aed8e6c
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	VWA5B2 NRXN1 HCN4 AP3B2 BSN	4.91e-05	186	95	5	b45cce768e4bf91da194fd9660cab7520dfb15ac
ToppCell	LPS-antiTNF-Epithelial_alveolar\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FSD1L LLGL2 NRXN3 IMPA2 IRX3	5.03e-05	187	95	5	201ff693e4756ee3e44762885b3a303a77eb535b
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRXN3 NRXN1 WSCD2 BSN ADCY1	5.03e-05	187	95	5	1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DENND2A IMPA2 PDGFRB OBSCN RYR2	5.03e-05	187	95	5	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	Endothelial-B\|World / lung cells shred on cell class, cell subclass, sample id	OLFML2A DENND2A PDE2A STAB2 FSCN1	5.16e-05	188	95	5	5959a88728812a5f4cbfa54eddc7a73ccbaa2f68
ToppCell	390C-Endothelial_cells-Endothelial-F_(Lymphatics)\|390C / Donor, Lineage, Cell class and subclass (all cells)	OLFML2A DENND2A PDE2A STAB2 FSCN1	5.16e-05	188	95	5	aa69e3f44d506f5ef358a3374ac5160d847c858f
ToppCell	390C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	OLFML2A DENND2A PDE2A STAB2 FSCN1	5.16e-05	188	95	5	1f40b959777d18ad88d239df8cca304f062ba04c
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	OLFML2A NRXN1 PDGFRB MRC2 IRX3	5.16e-05	188	95	5	de6f4889e0c5f39fbbaefd85526f645c6afa09d5
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	VWA5B2 NRXN1 HCN4 AP3B2 BSN	5.16e-05	188	95	5	c4c3b21ab723b0e9beff9ec84f8d68485f771528
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NRXN3 PDGFRB WSCD2 CSMD1 RYR2	5.29e-05	189	95	5	7fbe855bfdb47d35e040b04a80fe4b729a3764e8
ToppCell	facs-Lung-EPCAM-18m-Epithelial-Basal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MET NRXN1 WNT7B PAPLN PLXNB1	5.29e-05	189	95	5	783c1db856f2defe6f3b8748dd0bc29a8102f6d1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NRXN3 PDGFRB WSCD2 CSMD1 RYR2	5.29e-05	189	95	5	06b35abecd29f902cf251fcc1f6ad33db7ab08a2
ToppCell	facs-Lung-EPCAM-18m-Epithelial-respiratory_basal_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MET NRXN1 WNT7B PAPLN PLXNB1	5.29e-05	189	95	5	88b72fafbe58463543e0818f27f3dd9e5b4d34d2
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	DENND2A IMPA2 PDGFRB OBSCN RYR2	5.29e-05	189	95	5	d7ed96add29f219183c802895fbff519b627f635
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DENND2A PDGFRB MRC2 PAPLN RYR2	5.43e-05	190	95	5	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDGFRB IGSF9B CSMD1 ADCY1 RYR2	5.43e-05	190	95	5	73d94fbae92029745989a8712eed8b99fd84c193
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	VWA5B2 CRYBA2 LLGL2 NRXN1 ADCY1	5.43e-05	190	95	5	b5c6f3248c0c2f648e1578457c6a729ca22bf0da
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DENND2A PDGFRB MRC2 WNT2 RYR2	5.56e-05	191	95	5	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MET DENND2A NRXN3 FSTL3 UGCG	5.56e-05	191	95	5	9032aa974aa1b7b1095b8d1b58dcb087358a5001
ToppCell	10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PDE2A STAB2 BSN ADCY1 CRHBP	5.56e-05	191	95	5	dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MET DENND2A NRXN3 FSTL3 UGCG	5.56e-05	191	95	5	5717809a1476c20f65bce722c5a57cff92ee0d7a
ToppCell	droplet-Kidney-nan-18m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND2A PDGFRB MRC2 DEFB104A CSMD1	5.70e-05	192	95	5	38d7a24ae205ef91ed2e0f402d8022f2a9cdb243
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NRXN3 PDGFRB IGSF9B CSMD1 RYR2	5.70e-05	192	95	5	bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCell	droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND2A PDGFRB MRC2 DEFB104A CSMD1	5.70e-05	192	95	5	04d155897ed075c359933080e36a4ab2150b6e9f
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DENND2A PDGFRB MRC2 WNT2 RYR2	5.70e-05	192	95	5	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NRXN3 PDGFRB IGSF9B CSMD1 RYR2	5.70e-05	192	95	5	b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DENND2A PDGFRB MRC2 WNT2 RYR2	5.70e-05	192	95	5	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DENND2A PDGFRB MRC2 WNT2 RYR2	5.70e-05	192	95	5	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	droplet-Kidney-nan-18m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND2A PDGFRB MRC2 DEFB104A CSMD1	5.70e-05	192	95	5	84149a5c6c3b3c9b86aed77cf8e72d99ef099fab
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DENND2A PDGFRB MRC2 WNT2 RYR2	5.70e-05	192	95	5	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	390C-Epithelial_cells-Epithelial-A_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DENND2A PDE2A HMCN2 BSN	5.79e-05	98	95	4	a74fb790c135bd0d0033df3aca7b789d8b25e361
ToppCell	390C-Epithelial_cells-Epithelial-A_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DENND2A PDE2A HMCN2 BSN	5.79e-05	98	95	4	cb0941481aef9068d7dbce0d1b6cf125f482a98d
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFHR1 HMCN2 PDGFRB MRC2 MMP9	5.84e-05	193	95	5	dc8e62df6121ee99b156aca6b1b3ae555739b6f2
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	OLFML2A DENND2A MRC2 WNT2 RYR2	5.84e-05	193	95	5	acad568621ed677031797b8c2e34dafea798d681
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFHR1 HMCN2 PDGFRB MRC2 MMP9	5.84e-05	193	95	5	e2ee077fd381bd906e6b4329f22e7d106e422a7f
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	OLFML2A DENND2A MRC2 WNT2 RYR2	5.99e-05	194	95	5	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DENND2A PDGFRB MRC2 WNT2 RYR2	5.99e-05	194	95	5	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	OLFML2A PDE2A POLB ITPRIP CRHBP	5.99e-05	194	95	5	ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-Pulmonary_neuroendocrine\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	VWA5B2 NRXN1 HCN4 AP3B2 ADCY1	5.99e-05	194	95	5	ccff0b5814f5de2d42720018e7f5dc5dcdafb568
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	OLFML2A DENND2A PDE2A STAB2 FSCN1	6.14e-05	195	95	5	0ff59b073b88fab1f6ed98508714cab430c7d079
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HMCN2 CSMD1 MMP9 GRM6 ADCY1	6.14e-05	195	95	5	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HMCN2 CSMD1 MMP9 GRM6 ADCY1	6.14e-05	195	95	5	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	OLFML2A DENND2A PDE2A STAB2 FSCN1	6.14e-05	195	95	5	7e71b1707b34ce47fffadf6f64d9554768221fc6
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	OLFML2A DENND2A PDE2A STAB2 FSCN1	6.14e-05	195	95	5	3ea2b5ecb66faddeefffbf0d39fc7cb5abf35ad7
Disease	autism spectrum disorder (implicated_via_orthology)	MET NRXN3 NRXN1 PDGFRB KMT5B CHD9	8.92e-06	152	93	6	DOID:0060041 (implicated_via_orthology)
Disease	Liver carcinoma	OLFML2A MET STAB2 CSMD1 MMP9 WDR76 PGD CRHBP ZFP36	3.26e-05	507	93	9	C2239176
Disease	respiratory symptom measurement, COVID-19	RBM10 CSMD1 BRWD3 RAVER1	8.99e-05	74	93	4	EFO_0007939, MONDO_0100096
Disease	hepatocellular carcinoma (biomarker_via_orthology)	MET CSK PIK3R2 PCNA	3.86e-04	108	93	4	DOID:684 (biomarker_via_orthology)
Disease	decadienedioic acid (C10:2-DC) measurement	NUMB PAPLN	4.35e-04	10	93	2	EFO_0800598
Disease	hemopexin measurement	CFHR1 CRB1	5.31e-04	11	93	2	EFO_0008149
Disease	renal cell carcinoma (is_marker_for)	PDGFRB FRS2 MMP9 PCNA	7.32e-04	128	93	4	DOID:4450 (is_marker_for)
Disease	cholangiocarcinoma (biomarker_via_orthology)	MET MMP9	7.49e-04	13	93	2	DOID:4947 (biomarker_via_orthology)
Disease	pancreatic ductal carcinoma (is_marker_for)	MET MMP9 FSCN1	9.56e-04	61	93	3	DOID:3587 (is_marker_for)
Disease	cholangiocarcinoma (is_marker_for)	MET MMP9 FSCN1	1.10e-03	64	93	3	DOID:4947 (is_marker_for)
Disease	Schizoaffective disorder-bipolar type	STAB2 NRXN3	1.15e-03	16	93	2	EFO_0009965
Disease	creatinine measurement	PTPN9 WNT7B AP3B2 DUSP9 OBSCN NUMB CHD9 BSN BRWD3 DCAF12	1.17e-03	995	93	10	EFO_0004518
Disease	schizophrenia (implicated_via_orthology)	NRXN1 PDGFRB CSMD1	1.31e-03	68	93	3	DOID:5419 (implicated_via_orthology)
Disease	response to platinum based chemotherapy	NRXN3 ADCY1	1.45e-03	18	93	2	EFO_0004647
Disease	granulocyte percentage of myeloid white cells	DAGLB PDGFRB CHD9 NDUFS2 DCAF12	1.61e-03	268	93	5	EFO_0007997
Disease	longitudinal BMI measurement	ADAMTS6 WNT7B ADGRE4P	2.24e-03	82	93	3	EFO_0005937
Disease	Autism Spectrum Disorders	NRXN3 NRXN1 RYR2	2.48e-03	85	93	3	C1510586
Disease	glioblastoma (is_implicated_in)	PDGFRB MMP9	2.59e-03	24	93	2	DOID:3068 (is_implicated_in)
Disease	Cerebral Astrocytoma	MET MMP9	2.81e-03	25	93	2	C0750935
Disease	Intracranial Astrocytoma	MET MMP9	2.81e-03	25	93	2	C0750936
Disease	Astrocytoma	MET MMP9	2.81e-03	25	93	2	C0004114
Disease	Grade I Astrocytoma	MET MMP9	2.81e-03	25	93	2	C1704230
Disease	Subependymal Giant Cell Astrocytoma	MET MMP9	2.81e-03	25	93	2	C0205768
Disease	Mixed oligoastrocytoma	MET MMP9	2.81e-03	25	93	2	C0547065
Disease	Pilocytic Astrocytoma	MET MMP9	2.81e-03	25	93	2	C0334583
Disease	Juvenile Pilocytic Astrocytoma	MET MMP9	2.81e-03	25	93	2	C0280783
Disease	Diffuse Astrocytoma	MET MMP9	2.81e-03	25	93	2	C0280785
Disease	Childhood Cerebral Astrocytoma	MET MMP9	2.81e-03	25	93	2	C0338070
Disease	breast cancer (is_marker_for)	PDGFRB WNT2 WNT7B ZFP36	2.83e-03	185	93	4	DOID:1612 (is_marker_for)
Disease	brain cancer (implicated_via_orthology)	LLGL2 NUMB	3.04e-03	26	93	2	DOID:1319 (implicated_via_orthology)
Disease	Gemistocytic astrocytoma	MET MMP9	3.04e-03	26	93	2	C0334581
Disease	Protoplasmic astrocytoma	MET MMP9	3.04e-03	26	93	2	C0334580
Disease	Fibrillary Astrocytoma	MET MMP9	3.04e-03	26	93	2	C0334582

Protein segments in the cluster

Peptide	Gene	Start	Entry
SYRAGTRCSAIGFRL	LINC00588	31	Q9Y4M8
RGYEVGSTVFFRCRK	CSMD1	3231	Q96PZ7
CGSIRGGREDRTLYE	DNPH1	26	O43598
IRGVRVSDDGEYTCF	BTN1A1	111	Q13410
TCEDGFRARSGRTYF	ADGRE4P	31	Q86SQ3
ERDRHSGEFCTYGEL	CRYBA2	166	P53672
GGNSEYRDTTRRCRD	PGD	101	P52209
SSVYCVAFDRSGRRI	BRWD3	181	Q6RI45
DYLRSRGRSVLGGDC	CSK	276	P41240
YCRMLEEGSFRGRTA	DERL3	81	Q96Q80
SIRRSEDGTRFFGKC	ADAMTS20	1876	P59510
ACSRDYITSFLDSGR	ADAMTS6	446	Q9UKP5
CGTSDEYRFAGRTLT	AP3B2	1026	Q13367
GSLERCFLVYSERTG	RAVER1	156	Q8IY67
DRTGRYGATDRSQDD	RBM10	11	P98175
YERCIRGATADAART	ITPRIP	146	Q8IWB1
TTRFEEGGRRKCGQY	PTPN9	401	P43378
SISEGCGGRVTDYRI	INTS13	401	Q9NVM9
FEGRSYSACTTDGRS	MMP9	236	P14780
TRSRGRGRGDSCFYQ	GIGYF1	121	O75420
RGRGDSCFYQRSIEE	GIGYF1	126	O75420
RYSCIRREDVSGIAS	LLGL2	886	Q6P1M3
RGSRDRFTGESYTVL	FSD1L	361	Q9BXM9
AAIRTSDAGRYRCEA	HMCN2	1216	Q8NDA2
CYTCERRGTGAFKSR	KMT5B	321	Q4FZB7
DSTGSRVCRSGFVEY	LBHD1	181	Q9BQE6
VEDDRIYGGSSRSRA	BSN	3431	Q9UPA5
TLRSEGFDTYRCDRN	PCNA	51	P12004
TRDACYTREGRAEDG	PLXNB1	336	O43157
RVSSVYEARCTGERD	KIAA0232	1336	Q92628
LFYRGVDDSTGFRTR	PDE2A	486	O00408
RELGSSARFVYEACG	DCAF8	161	Q5TAQ9
GRTCEREASILSYDG	NRXN3	676	Q9Y4C0
DCRSRELYESARIGG	DUSP9	26	Q99956
SIERGAFEGARYSRS	MRC2	1441	Q9UBG0
CEGYRGVEIRDLSSS	MICALL1	16	Q8N3F8
GYLGRSCEREATVLS	NRXN1	706	Q9ULB1
RDTRLTDGSYFGEIC	HCN3	481	Q9P1Z3
CTEERLYTGRRGRGA	IMPA2	136	O14732
SYFGEICLLTRGRRT	HCN4	656	Q9Y3Q4
GSRGDCYDRYLCRVE	NDUFS2	321	O75306
TRQDEGTYSCRVGED	OBSCN	861	Q5VST9
GTYSCRVGEDSVDFR	OBSCN	866	Q5VST9
DGTFLIRESSQRGCY	PIK3R2	641	O00459
GTRDCYEVLGVSRSA	DNAJC25	46	Q9H1X3
GTSRRRGLRACDEEF	ADCY1	26	Q08828
RSNGYGRTECFRVEK	CHD9	1486	Q3L8U1
YRSTRRLSEEEFGGF	C17orf99	236	Q6UX52
RKCTGEERIGRDSTY	GRM6	381	O15303
GYDGRSRLSSVECLD	KLHL12	336	Q53G59
FRSGKVAFRDCEGRY	FSCN1	216	Q16658
RYIDFCESGLSRRSI	CRHBP	136	P24387
VLTGEDGSRRFGYCR	DENND2A	636	Q9ULE3
SRERGSGIRSVSFYE	DCAF12	336	Q5T6F0
CRSRTTDYDLVGGDQ	DAGLB	311	Q8NCG7
GSDGATYRDECELRA	FSTL3	136	O95633
GAIRSRGISSECLDY	GALNT4	446	Q8N4A0
GYDSNLFSFESGRRC	FRS2	66	Q8WU20
GYDSNLFSFESGRRC	FRS3	66	O43559
RSEFELDRICGYGTA	DEFB104A	21	Q8WTQ1
RTGRYRLRCGGTAEE	UGCG	376	Q16739
YARSTRGCLEAGLES	FBXO41	636	Q8TF61
RTGESAEFVCKRGYR	CFHR1	291	Q03591
YCRMLEEGSFRGRTA	DERL2	81	Q9GZP9
DNLSRTFYGGRDCSD	CRB1	426	P82279
DAVTSLCFGRYGRED	BBS1	371	Q8NFJ9
EVCSGTGERFRIFRA	RYR2	1076	Q92736
SEYIATVCGSFRRGA	POLB	171	P06746
CVEGYARRLRSSSRG	PPRC1	471	Q5VV67
SVSEDLGCRRGDFSR	GARNL3	26	Q5VVW2
QRGFSGIFEDRSYIC	PDGFRB	176	P09619
DYDGGRTRSDIVSRA	PDIA6	251	Q15084
CSRVRSGRARVEDFY	OLFML2A	61	Q68BL7
ARASYGVRRGRVCFE	HNRNPUL1	246	Q9BUJ2
RSRTDEEGNAYGSER	IRX3	196	P78415
AFLTCSRTGRAREAY	GPR68	306	Q15743
RNFDRAFSYICRDGT	NUMB	121	P49757
SSGCEARRDEYRTEF	MET	406	P08581
RLYFSAEEGGERSVC	TMEM161A	156	Q9NX61
SQGRCGTRFLTTYDR	PIP4K2B	131	P78356
SSYSDFISCDRTGRR	PKIG	6	Q9Y2B9
SSVRDDCPLRGYSDR	RBMXL2	246	O75526
TRESDAGTYVFCVER	SIGLEC12	111	Q96PQ1
GCSADVRYGIDFSRR	WNT7B	151	P56706
ESRDDRCRLFEYGQG	USP42	1301	Q9H9J4
DYCIRDREAGSLGTA	WNT2	276	P09544
FDRTGRRIFTGSDDC	PHIP	191	Q8WWQ0
CAEFDGAEFQGRRYR	PAPLN	91	O95428
TSVSREDRGAYTCRA	IGSF9B	196	Q9UPX0
TELCRTFSESGRCRY	ZFP36	106	P26651
ITSGSVGVRDCRYTF	STAB2	61	Q8WWQ8
SVYFCRVELDTRRSG	PILRB	121	Q9UKJ0
SECGDRSIFEGRTRY	PRSS55	51	Q6UWB4
AGDDRFGRRVVTFSC	ARHGAP8	26	P85298
LGYCSLFRVDGFRSR	VWA5B2	556	Q8N398
YDGTLRCGDFSRAIF	WDR76	381	Q9H967
FRDTGEASSIARRYG	WSCD2	76	Q2TBF2
YRDDTFVGRSTGTRA	KIAA1522	241	Q9P206